ArticleFrontiers in toxicology2026
Invisible victims: rising pediatric cocaine exposures in France (2020-2024) - insights from the national poison center database.
Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cocaine use remains prevalent in Europe and has been associated with pediatric exposures through accidental ingestion, passive inhalation, and perinatal or postnatal transmission, potentially leading to significant toxicity in young children. Objective: This study aimed to quantify the number of pediatric cocaine exposures for which consultation with a French poison center was requested, characterize clinical presentations and severity, evaluate medical interventions and outcomes, and assess child protection service involvement. Methods: We conducted a retrospective observational study of children aged 0-10 years with suspected or confirmed cocaine exposure reported to French Poison Centers from 1 January 2020, to 31 December 2024. Data collected included demographics, exposure route, clinical manifestations, toxicological analyses, treatments, outcomes, and Poisoning Severity Score (PSS). Results: A total of 113 suspected pediatric exposures were identified, of which 76 (67%) were confirmed by toxicological analysis. Median age was 1.8 years, and 63 children were younger than 3 years. Exposure routes included intrauterine exposure (n = 7), breastfeeding (n = 12), ingestion (n = 9), and inhalation (n = 1). Most cases were symptomatic, with 25 minor (PSS 1), 24 moderate (PSS 2), and 8 severe cases (PSS 3), one fatality (PSS 4). No consistent association between measured cocaine or metabolite concentrations and clinical severity was observed in the limited number of cases with quantitative data (n = 15). Supportive care was sufficient in most cases, while 17 children required specific medical interventions. Conclusion: Pediatric cocaine exposures represent a significant clinical and public health concern, occurring through multiple pathways without predictable dose-response relationships. Clinical assessment must be guided by physical examination rather than quantitative toxicology alone. Prevention efforts must target households with substance use disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.